Zimmer Biomet Holdings, Inc. (BVMF:Z1BH34)

Market Cap	94.64B
Revenue (ttm)	42.69B
Net Income (ttm)	4.29B
Shares Out	n/a
EPS (ttm)	21.49
PE Ratio	22.05
Forward PE	10.63
Dividend	0.91 (0.79%)
Ex-Dividend Date	Sep 29, 2025

Volume	n/a
Average Volume	47
Open	115.00
Previous Close	115.00
Day's Range	115.00 - 115.00
52-Week Range	115.00 - 157.60
Beta	0.61
RSI	30.03
Earnings Date	Feb 5, 2026

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open hear...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1927
• Employees: 17,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: Z1BH34

Financial Performance

In 2024, Zimmer Biomet Holdings's revenue was $7.68 billion, an increase of 3.85% compared to the previous year's $7.39 billion. Earnings were $903.80 million, a decrease of -11.74%.

Financial numbers in USD